Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVI-Brain-1 in recurrent Grade IV Glioma
NCT01290692Phase 2Completed
- Sponsor
- TVAX Biomedical
- Start
- Jun 2011
- Primary completion
- Dec 2013
- Modality
- Prophylactic Vaccines, Cancer Vaccines, Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of TVI-Brain 1 in glioblastoma (GBM), sponsored by TVAX Biomedical. Started Jun 2011; status: completed.
02
Drugs
TVI-Brain 1
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01290692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01290692.